Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

50,425 public trials 10,704 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology - Parkside Santa Monica, California, United States
View all 89 locations
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details
Recruiting

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

NCT07218146

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Yale Cancer Center/Clinical Trials Office New Haven, Connecticut, United States
View all 155 locations
View Trial Details
Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

NCT07144319

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • Oslo University Hospital Oslo, Norway
View Trial Details
Recruiting

Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT

NCT05442957

Conditions
Body Image, Body Image Disturbance, Head and Neck Cancer, +6 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Pennsylvania State University Hershey, Pennsylvania, United States
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 31 locations
View Trial Details
Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

NCT07291037

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Goodyear, Arizona, United States
  • Research Site Duarte, California, United States
View all 206 locations
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 19 locations
View Trial Details

Related conditions